Gene: ZNF213
Official Full Name: zinc finger protein 213provided by HGNC
Gene Summary: C2H2 zinc finger proteins, such as ZNF213, have bipartite structures in which one domain binds DNA or RNA and the other modulates target gene expression.[supplied by OMIM, Apr 2004]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34513 | ZNF213 Knockout cell line (HeLa) | Human | ZNF213 | 1:3~1:6 | Negative | Online Inquiry |
KO34514 | ZNF213 Knockout cell line (HCT 116) | Human | ZNF213 | 1:2~1:4 | Negative | Online Inquiry |
KO34515 | ZNF213 Knockout cell line (HEK293) | Human | ZNF213 | 1:3~1:6 | Negative | Online Inquiry |
KO34516 | ZNF213 Knockout cell line (A549) | Human | ZNF213 | 1:3~1:4 | Negative | Online Inquiry |
ZNF213 Gene Knockout Cell Lines represent a groundbreaking tool in molecular biology designed to facilitate the study of gene function and the intricate pathways associated with ZNF213, a gene implicated in various physiological processes and diseases. These specialized cell lines have been engineered through CRISPR-Cas9 technology, which allows for the precise deletion of the ZNF213 gene, resulting in a model that aids in understanding gene expression, regulatory mechanisms, and potential therapeutic targets.
The key functions of ZNF213 Gene Knockout Cell Lines hinge on their ability to eliminate the expression of ZNF213, thus providing researchers with an invaluable system for the investigation of its role in cellular processes. By comparing these knockout lines to wild-type controls, researchers can delineate the effects of ZNF213 deletion on cell proliferation, differentiation, and response to external stimuli. This model has far-reaching implications for identifying novel pharmacological targets, particularly in the context of cancers and metabolic disorders where ZNF213 dysregulation is a concern.
In terms of scientific importance, these cell lines are critical in both academic and clinical research settings. They furnish an effective means to explore gene function, develop gene therapies, and assess the efficacy of new drugs in a controlled environment, thereby accelerating the pace of biomedical research. The advantage of utilizing ZNF213 Gene Knockout Cell Lines lies in their specificity and reproducibility, offering a higher degree of confidence in experimental outcomes compared to traditional methods which may involve more variable changes in gene expression.
What sets these cell lines apart from alternatives is their well-characterized nature, combined with the rapid, straightforward methodology used for their creation. Researchers can save time and resources while still ensuring robust data quality. Furthermore, the accessibility of these knockout models enables a broader range of research applications—from basic genetic studies to translational medicine.
Ultimately, ZNF213 Gene Knockout Cell Lines provide a versatile solution for those dedicated to advancing genetic research and therapeutic innovations. Our company's commitment to quality and precision in biological product development ensures that users receive a reliable tool that will enhance their studies and contribute to the scientific community's understanding of ZNF213 and its implications in health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.